AIM - AIM ImmunoTech Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
330
367
437
92
Cost of Revenue
958
884
1,183
1,108
Gross Profit
-628
-517
-746
-1,016
Operating Expenses
Research Development
4,201
4,778
4,098
5,107
Selling General and Administrative
7,187
6,201
6,572
7,681
Total Operating Expenses
11,388
10,979
10,670
12,788
Operating Income or Loss
-12,016
-11,496
-11,416
-13,804
Interest Expense
787
502
139
0
Total Other Income/Expenses Net
2,814
2,139
3,208
6,173
Income Before Tax
-9,952
-9,813
-8,259
-7,502
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-9,952
-9,813
-8,259
-7,502
Net Income
-9,952
-9,813
-8,259
-7,502
Net Income available to common shareholders
-9,952
-9,813
-8,259
-7,502
Reported EPS
Basic
-
-9.68
-12.76
-14.96
Diluted
-
-9.68
-12.76
-14.96
Weighted average shares outstanding
Basic
-
1,004
652
496
Diluted
-
1,004
652
496
EBITDA
-
-8,433
-7,109
-6,199